Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
about
Evolving treatment paradigms for chemotherapy-induced nausea and vomitingA Dunnione Compound MB12662 Improves Cisplatin-Induced Tissue Injury and EmesisComparison between 5-day aprepitant and single-dose fosaprepitant meglumine for preventing nausea and vomiting induced by cisplatin-based chemotherapy.Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIVA Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy.Safety evaluation of aprepitant for the prevention of chemotherapy-induced nausea and vomiting.Fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting.Safety and efficacy of commonly used antiemetics.Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy.Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populationsThe Role of Neurogenic Inflammation in Blood-Brain Barrier Disruption and Development of Cerebral Oedema Following Acute Central Nervous System (CNS) Injury.Automated analysis of delayed emesis in the telemetered ferret: detection of synergistic effects of aprepitant and ondansetron.Neurokinin 1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant.Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial.
P2860
Q27024463-6527D41B-D186-435B-8C48-9DFB2918AE0CQ36015715-21A82316-EF45-4DE9-8523-BA7789D32A78Q36400372-894BD694-71AC-4F83-9012-C81FD0EFDB22Q36937565-0E4FBC8B-0B19-41B3-846E-77854C4DF3D2Q37570350-DD7BDE9E-1445-46E2-8868-B220E86111E1Q37854702-35165B2F-AEFD-4AD5-ABFE-5A54D232941AQ37982438-3FD3B731-CF48-4871-B256-CAB1EF558CA6Q38570496-EC55CF2C-9863-43AE-84E4-CF0CB6331616Q39275766-06E989FB-296C-4F8F-9808-F10E28679AF5Q40978787-56D7CEC9-A341-4986-9B85-BC11C17CA27BQ41386264-0739D487-037A-4DC7-A3B6-C9DCEBE8770EQ41574379-DC0C7C7B-8BFC-49AE-98CE-C197C6C247DCQ46044510-616FD249-C6CD-4055-84D9-468148E0D3B0Q47800047-C2EBC9C4-C0F5-4861-88AF-194046C5418DQ48076549-8E5E7DE4-463E-472D-BF73-6EEB8BAA110D
P2860
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@ast
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@en
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@nl
type
label
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@ast
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@en
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@nl
prefLabel
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@ast
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@en
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@nl
P2093
P356
P1476
Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets.
@en
P2093
Alan P Watt
Brian J Dean
Carolann Keohane
Donald F Hora
F David Tattersall
Gary G Chicchi
Ray Bakhtiar
Richard Hargreaves
Rosa I Sanchez
Shuet-Hing L Chiu
P304
P356
10.1124/DMD.31.6.785
P577
2003-06-01T00:00:00Z